A biotechnology journal that was inundated with paper-mill submissions in 2021 — and claimed in 2023 that it had tackled the problem — still harbours hundreds of dubious papers, an analysis by ...

The paper, published in 2020 in the International Journal of Antimicrobial Agents, originally claimed that treatments with hydroxychloroquine, an anti-malaria drug, reduced virus levels in COVID ...